Long-term efficacy of AZAthioprine (aza) in inflammatory bowel disease (IBD) -: a European Multicenter study in 1200 patients with Crohn's disease (CD) and ulcerative colitis (UC)

被引：0
|
作者：
Holtmann, MH
Krummenauer, F
Claas, C
Kremeyer, K
Lorenz, D
Rainer, O
Vogel, I
Galle, PR
Boecker, U
Boehm, S
Büming, C
Duchmann, R
Gerken, G
Herfarth, H
Lingering, N
Kruis, W
Reinshagen, M
Schmidt, J
Stallmach, A
Stein, J
Sturm, A
Hommes, D
D'Haens, G
Rutgeerts, P
Neurath, M
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [21] Control of Toll-Like Receptor (TLR) Signalling in Inflammatory Bowel Disease (IBD): Differential Expression of Key Regulators of TLRS in Ulcerative Colitis (UC) and Crohn's Disease (CD)
    Brint, Elizabeth
    Quigley, Eamonn M.
    Shanahan, Fergus
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A254 - A254
  • [22] Vedolizumab Long-term Efficacy and Safety in the Treatment of ulcerative Colitis and Crohn's Disease in Adults
    不详
    [J]. VISCERAL MEDICINE, 2017, 33 (05) : 391 - 391
  • [23] Is serology for ulcerative colitis and Crohn's disease an improvement on existing screening tests for inflammatory bowel disease (IBD) in children?
    Khan, K
    Ferrenci, D
    Schwarzenberg, SJ
    Kennedy, M
    Ramalingham, A
    Stafford, R
    Greenwood, D
    Weisdorf, S
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A274 - A274
  • [24] MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY OF LONG-TERM TREATMENT
    Petrolati, A.
    Nasoni, S.
    Altavilla, N.
    Cipolla, R.
    Fenderico, P.
    Forlini, G.
    Rossi, Z.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S134
  • [25] Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn's disease (CD) and 2 years in ulcerative colitis (UC)
    Ghosh, Subrata
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Colombel, Jean-Frederic
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 107 - 107
  • [26] COMPLICATIONS OF MYOCARDITIS IN INFLAMMATORY BOWEL DISEASE (IBD): A POPULATION-BASED COMPARATIVE STUDY BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE
    Dasu, Neethi
    Khalid, Yaser
    Blair, Brian
    Chhoun, Christopher
    Joo, Lucy
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 : S38 - S39
  • [27] COMPLICATIONS OF MYOCARDITIS IN INFLAMMATORY BOWEL DISEASE (IBD): A POPULATION-BASED COMPARATIVE STUDY BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE
    Dasu, Neethi
    Khalid, Yaser
    Blair, Brian
    Chhoun, Christopher
    Joo, Lucy
    [J]. GASTROENTEROLOGY, 2022, 162 (03) : S38 - S39
  • [28] Incidence of benign infections in inflammatory bowel disease (IBD) patients treated with azathioprine (AZA)
    Seksik, Philippe
    Cosnes, Jacques
    Nion-Larmuier, Isabelle
    Gendre, Jean-Pierre
    Beaugene, Laurent
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A72 - A72
  • [29] Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan
    Tokita, Kazuhide
    Shimizu, Hirotaka
    Takeuchi, Ichiro
    Shimizu, Toshiaki
    Arai, Katsuhiro
    [J]. PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2022, 25 (06) : 461 - 472
  • [30] Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine mercaptopurine
    Wahed, M.
    Louis-Auguste, J. R.
    Baxter, L. M.
    Limdi, J. K.
    McCartney, S. A.
    Lindsay, J. O.
    Bloom, S. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (06) : 614 - 620
12345